Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

8 Stocks to Sell After the Presidential Election

With the drama over the presidential election appearing to come to a close, these companies may represent stocks to sell as the Biden administration forges a new direction for the country.

Why Online Dating in China Is Much Better for Momo Stock

With coronavirus cases spiking in many countries, you might be tempted to overlook Momo stock but that might be a mistake.

Teladoc Is the No. 1 Telehealth Stock to Buy

With coronavirus cases worsening, the bullish narrative for TDOC stock seemingly is never better. Still, there are longer-term reasons to consider Teladoc Health.

9 OTC Stocks With Plenty of Potential

No one should ever bet on OTC stocks without serious consideration about their risk profile. However, if you know what you’re getting involved in, this much-maligned sector could offer a path to significant growth.

You’re Probably Asking the Wrong Question About Li Auto

On paper, LI stock seems like a great bet on the wildly explosive EV market in China. But you should check under the hood first.